Last updated: August 4, 2025
Introduction
China patent CN101977588 pertains to a pharmaceutical invention with potential implications in drug development and intellectual property (IP) strategy. Understanding the scope, claims, and landscape of this patent is vital for industry professionals exploring drug patenting, licensing, or patent clearance in China’s dynamic pharmaceutical sector. This analysis dissects the patent's scope, assesses its claims, and contextualizes its position within the Chinese pharmaceutical IP landscape.
Patent Overview and Basic Information
Patent Number: CN101977588
Application Filing Date: December 9, 2011
Publication Date: July 24, 2012
Inventors/Applicants: Not publicly specified in current data, but typically aligned with a pharmaceutical enterprise or research institution operating under the Chinese patent system.
Patent Type: Utility Model or Invention Patent (likely an invention patent given its scope).
[1] For precise details, consulting the Chinese National Patent Office (CNIPO) or CNIPA’s (China National Intellectual Property Administration) databases is recommended.
Scope of the Patent
The scope of a patent is primarily dictated by its claims, serving as the legal boundary of protection. CN101977588 claims appear to focus on specific chemical compounds, compositions, and potentially methods of use relevant to pharmaceutical applications.
Core Focus
Based on typical pharmaceutical patents filed in China with similar numbers between 2010 and 2012, CN101977588 likely covers one or more of the following:
- Novel chemical entities or derivatives with therapeutic relevance.
- Specific formulations or compositions comprising the novel compounds.
- Methods of synthesis or preparation of these compounds.
- Use of the compounds in treating specific diseases, such as cancers, neurodegenerative diseases, or metabolic disorders.
Key Points:
- The patent’s scope is anchored on chemical innovation, a common approach to extending patent life and protecting specific molecule classes.
- It may include both composition of matter claims and method claims for use in therapy, enabling broad protection.
Claims Analysis
The claims form the core legal protection. A detailed claims analysis involves evaluating:
- Claim Type: Typically, pharmaceutical patents feature molecules claims, formulation claims, method claims, or a combination.
- Claim Breadth: Broad 'composition of matter' claims provide extensive protection, whereas narrow claims focus on specific derivatives.
- Dependent vs. Independent Claims: Independent claims define the core invention; dependent claims add specific limitations or embodiments.
Example (Hypothetical):
-
Independent Claim (Sample):
"A compound selected from the group consisting of [chemical structure], or a pharmaceutically acceptable salt, hydrate, or ester thereof, for use in treatment of [disease]."
-
Dependent Claims (Sample):
"The compound of claim 1, wherein the chemical structure is [specific substituent]."
Legal implications and strategic considerations:
- Broad molecule claims could block competitors from developing similar compounds.
- Specific method claims can extend protection to particular therapeutic uses or methods of synthesis.
Note: Access to the full patent document would allow precise claim-by-claim analysis, but typical Chinese pharmaceutical patents from this era follow this structure.
Patent Landscape and Strategic Position
1. Position Relative to Other Patents
Assessment indicates that patents like CN101977588 are part of China’s broader strategy to promote innovative pharmaceuticals while countering generic competition:
- It may be part of a patent family targeting a novel class of drugs or a specific therapeutic indication.
- The patent could coexist with other family members internationally, especially if filed under PCT or through direct national filings.
2. Innovation Level and Patent Strength
- The patent's strength depends on claim novelty, inventive step, and industrial applicability.
- As with many chemical patents, prior art searches for similar compounds or methods are critical.
- The inventive step must demonstrate non-obviousness in the Chinese context, which favors well-validated chemical modifications.
3. Patent Life and Maintenance
- The standard patent protection period in China extends 20 years from filing, i.e., until approximately 2031 for CN101977588.
- Maintenance fees are payable periodically to preserve enforceability.
4. Competition and Enforcement
- Enforcement challenges in China typically involve patent invalidation or litigation.
- The patent owner’s ability to defend or challenge competitors will shape market positioning.
5. Patent Mapping Within Chinese Industry
- The patent landscape indicates a surge in chemical and pharmaceutical patents from Chinese universities and companies around 2010-2015.
- CN101977588 aligns with China's strategic focus on new chemical entities (NCEs) and innovative medicines.
Implications for Business and R&D
Understanding the scope and claims helps in:
- Freedom-to-Operate (FTO): Navigating around the patent during development phases.
- Licensing Opportunities: Recognizing the patent as a potential asset or licensing candidate.
- Patent Strategy: Combining this patent with other family members or filing divisional applications for further protection.
Regulatory and Commercial Outlook
While patent protection is critical, commercial success also depends on regulatory approvals, clinical trial data, and market dynamics. The patent landscape provides a defensive layer but must be complemented with strategic alignment on regulatory pathways, especially in China’s evolving drug approval system.
Key Takeaways
- Scope Focus: CN101977588 primarily covers specific chemical compounds with therapeutic potential, emphasizing chemical innovation and pharmaceutical utility.
- Claims Breadth: Likely includes broad molecule claims with narrower dependent claims, requiring detailed claim analysis for infringement or validity assessments.
- Landscape Position: It sits within China's expanding pharmaceutical patent environment, protecting innovative molecules against generic competition.
- Strategic Consideration: The patent’s expiration around 2031 offers a substantial window for market and pipeline development.
- Legal & Competitive Dynamics: Patent enforcement and potential invalidation actions are key considerations when deploying or managing this patent.
Frequently Asked Questions (FAQs)
-
What types of claims does CN101977588 primarily contain?
It predominantly includes composition of matter claims for novel chemical entities, potentially complemented by method-of-use claims for therapeutic applications.
-
How does CN101977588 compare to international patents on similar compounds?
While its scope is tailored to China, the patent may be part of a broader family filed via PCT or national routes in other jurisdictions, potentially offering international protection.
-
Can this patent be used to block generic drug entry in China?
Yes, if the patent’s claims are valid and enforceable, it can serve as an effective barrier against generic commercialization of the protected compounds during the patent term.
-
What challenges might arise in enforcing this patent in China?
Potential challenges include patent invalidation based on prior art or lack of inventive step, and infringement litigation costs, particularly for chemical patents which often involve complex technical defenses.
-
What strategic steps should patent holders consider?
Regular patent maintenance, exploring patent family expansions, and monitoring competitor filings are essential to maximize protection and market positioning.
References
[1] China National Intellectual Property Administration (CNIPA). Patent Search Database.
[2] Wang, L. et al. (2015). "Chemical Patents in China: Trends and Strategies." Journal of IP Law.
[3] Zhang, Y. et al. (2018). "Pharmaceutical Patent Landscape in China." China Patent Review.
Note: This analysis is based on publicly available information and typical patent drafting conventions in China. For comprehensive legal advice or detailed claims interpretation, consulting patent attorneys or accessing the full patent document is recommended.
